2016
Paradigm Shift in the Surveillance and Management of Dysplasia in Inflammatory Bowel Disease (West)
Soetikno R, Kaltenbach T, McQuaid KR, Subramanian V, Kumar R, Barkun AN, Laine L. Paradigm Shift in the Surveillance and Management of Dysplasia in Inflammatory Bowel Disease (West). Digestive Endoscopy 2016, 28: 266-273. PMID: 26866420, DOI: 10.1111/den.12634.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH KeywordsColonoscopyColorectal NeoplasmsEarly Detection of CancerHumansInflammatory Bowel DiseasesPopulation SurveillancePractice Guidelines as TopicConceptsManagement of dysplasiaColorectal cancerUlcerative colitisInflammatory bowel disease colitisCrohn's disease (CD) colitisInflammatory bowel diseaseEarly colorectal cancerDysplasia associated lesionHigh-definition colonoscopyInstitute of MedicineNew surveillance paradigmMost dysplasiaColorectal dysplasiaResectable lesionsSurveillance colonoscopyBowel diseaseGRADE methodologyAssociated lesionsTargeted biopsiesConsensus statementHigh riskGeneral populationEndoscopic recognitionGuideline developmentDysplasia
2015
SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease
Laine L, Kaltenbach T, Barkun A, McQuaid KR, Subramanian V, Soetikno R, Panel S, East J, Farraye F, Feagan B, Ioannidis J, Kiesslich R, Krier M, Matsumoto T, McCabe R, Mönkemüller K, Odze R, Picco M, Rubin D, Rubin M, Rubio C, Rutter M, Sanchez-Yague A, Sanduleanu S, Shergill A, Ullman T, Velayos F, Yakich D, Yang Y. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointestinal Endoscopy 2015, 81: 489-501.e26. PMID: 25708752, DOI: 10.1016/j.gie.2014.12.009.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements